Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Stockholders for Nektar Therapeutics, held on June 4, 2026. The filing was submitted on June 5, 2026. The company is incorporated in Delaware and its common stock (NKTR) trades on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes.
Material Changes and Voting Results
The following proposals were submitted to a vote of security holders:
- Proposal 1 (Election of Directors): Howard W. Robin was elected to the Board of Directors to serve until the 2029 Annual Meeting. Jeffrey Ajer, Diana Brainard, Robert Chess, R. Scott Greer, and Roy Whitfield continue to serve.
- Proposal 2 (Equity Plan Amendment): Shareholders approved an amendment to the Amended and Restated 2017 Performance Incentive Plan, increasing the authorized share pool by 3,000,000 shares.
- Proposal 3 (Auditor Ratification): The selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was ratified.
- Proposal 4 (Executive Compensation): The non-binding advisory resolution regarding executive compensation was approved.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on financial outlook, specific risks, contingencies, or unusual items. The document serves as a record of the shareholder vote outcomes.
Key Facts for Investor Verification
- Howard W. Robin received 13,164,879 votes "For" but also faced significant opposition with 4,975,288 votes "Against."
- The equity plan amendment to add 3 million shares was approved with 13,160,661 votes "For" versus 4,902,925 "Against."
- Ernst & Young LLP was overwhelmingly ratified as the auditor with 22,591,556 votes "For" and only 118,592 "Against."
- Broker non-votes were significant for Proposals 1, 2, and 4 (4,588,835 each) but were zero for the auditor ratification (Proposal 3).